Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve). [electronic resource]
- European journal of heart failure Jul 2014
- 778-87 p. digital
Adrenergic beta-Antagonists--therapeutic use Aged Aged, 80 and over Angiotensin II Type 1 Receptor Blockers--therapeutic use Atrial Fibrillation--mortality Biphenyl Compounds--therapeutic use Female Heart Failure--drug therapy Heart Rate--physiology Hospitalization--statistics & numerical data Humans Irbesartan Male Middle Aged Prognosis Stroke Volume Tetrazoles--therapeutic use Ventricular Dysfunction, Left--drug therapy